Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.

Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Abstract Text:

    satoshi yamashitaSatoshi Yamashita,satoru takahashiSatoru Takahashi,nathalie mcdonellNathalie McDonell,naoko watanabeNaoko Watanabe,tohru niwaTohru Niwa,kosuke hosoyaKosuke Hosoya,yoshimi tsujinoYoshimi Tsujino,tomoyuki shiraiTomoyuki Shirai,toshikazu ushijimaToshikazu Ushijima,satoshi yamashitaSatoshi Yamashita,satoru takahashiSatoru Takahashi,nathalie mcdonellNathalie McDonell,naoko watanabeNaoko Watanabe,tohru niwaTohru Niwa,kosuke hosoyaKosuke Hosoya,yoshimi tsujinoYoshimi Tsujino,tomoyuki shiraiTomoyuki Shirai,toshikazu ushijimaToshikazu Ushijima,

    To identify methylation-silenced genes in prostate cancers, a microarray analysis for genes up-regulated by treatment with a demethylating agent, 5-aza-2'-deoxycytidine, was performed using three rat prostate cancer cell lines. Eight genes (Aebp1, Dysf, Gas6, LOC361288, Nnat, Ocm, RGD1308119, and Tgfbr2) were re-expressed at 16-fold or more, and their promoter CpG islands were shown to be densely methylated in the cancer cell lines. From the eight genes, Tgfbr2, a key mediator of transforming growth factor-beta (TGF-beta) signaling that has been strongly implicated in human and rat prostate carcinogenesis, was selected, and its silencing in primary samples was analyzed further. Tgfbr2 was methylated and markedly down-regulated in three of seven 3,2'-dimethyl-4-aminobiphenyl-induced invasive adenocarcinomas in the dorsolateral lobe of the rat prostate. In humans, marked down-regulation of TGFBR2 protein was observed in 12 of 20 high-grade prostatic intraepithelial neoplasia and 36 of 60 prostate cancers. DNA methylation of the human TGFBR2 promoter CpG islands repressed transcription, if present, but neither methylation nor mutation were detected in 27 human prostate cancers analyzed. Methylation silencing of rat Tgfbr2 was associated with histone H3 lysine 9 trimethylation, whereas decreased expression of human TGFBR2 was mainly due to decreased transcription activity, sometimes in concert with histone deacetylation and H3 lysine 27 trimethylation. The identification of methylation silencing of Tgfbr2 in rat prostate cancers, in accordance with TGFBR2 down-regulation in human prostate cancers, will enable us to analyze how aberrant methylation is induced in vivo and identify factors that promote and suppress the induction of aberrant methylation.

    Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Publishing Authors By Initials

    s yamashitaS Yamashita,s takahashiS Takahashi,n mcdonellN McDonell,n watanabeN Watanabe,t niwaT Niwa,k hosoyaK Hosoya,y tsujinoY Tsujino,t shiraiT Shirai,t ushijimaT Ushijima,s yamashitaS Yamashita,s takahashiS Takahashi,n mcdonellN McDonell,n watanabeN Watanabe,t niwaT Niwa,k hosoyaK Hosoya,y tsujinoY Tsujino,t shiraiT Shirai,t ushijimaT Ushijima,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Cancer research

    VOLUME: 68

    Page Numbers: 2112-21

    Journal Abbreviation: Cancer Res.

    ISSN: 1538-7445

    DAY: 1

    MONTH: Apr

    YEAR: 2008

    Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 2984705

    Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.

    AFFILIATION: Carcinogenesis Division, National Cancer Center Research Institute, Chuo-ku, Tokyo, Japan.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Cancer Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News